全文获取类型
收费全文 | 2964篇 |
免费 | 193篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 138篇 |
妇产科学 | 58篇 |
基础医学 | 419篇 |
口腔科学 | 57篇 |
临床医学 | 439篇 |
内科学 | 629篇 |
皮肤病学 | 45篇 |
神经病学 | 292篇 |
特种医学 | 52篇 |
外科学 | 268篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 274篇 |
眼科学 | 33篇 |
药学 | 174篇 |
中国医学 | 2篇 |
肿瘤学 | 242篇 |
出版年
2024年 | 4篇 |
2023年 | 22篇 |
2022年 | 39篇 |
2021年 | 72篇 |
2020年 | 55篇 |
2019年 | 57篇 |
2018年 | 68篇 |
2017年 | 67篇 |
2016年 | 64篇 |
2015年 | 76篇 |
2014年 | 94篇 |
2013年 | 143篇 |
2012年 | 222篇 |
2011年 | 238篇 |
2010年 | 108篇 |
2009年 | 103篇 |
2008年 | 186篇 |
2007年 | 186篇 |
2006年 | 184篇 |
2005年 | 200篇 |
2004年 | 193篇 |
2003年 | 174篇 |
2002年 | 194篇 |
2001年 | 33篇 |
2000年 | 29篇 |
1999年 | 30篇 |
1998年 | 34篇 |
1997年 | 23篇 |
1996年 | 23篇 |
1995年 | 22篇 |
1994年 | 26篇 |
1993年 | 20篇 |
1992年 | 16篇 |
1991年 | 21篇 |
1990年 | 16篇 |
1989年 | 17篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 7篇 |
1985年 | 5篇 |
1984年 | 12篇 |
1983年 | 13篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1979年 | 4篇 |
1978年 | 7篇 |
1976年 | 3篇 |
1975年 | 5篇 |
1972年 | 2篇 |
1971年 | 3篇 |
排序方式: 共有3166条查询结果,搜索用时 31 毫秒
991.
Noble SI Shelley MD Coles B Williams SM Wilcock A Johnson MJ;Association for Palliative Medicine for Great Britain Ireland 《The lancet oncology》2008,9(6):577-584
Venous thromboembolism is common in patients with cancer. However, no management guidelines exist for venous thromboembolism specific to patients with advanced progressive cancer. To help develop recommendations for practice, we have done a comprehensive review of anticoagulation treatment in patients with cancer, with particular focus on studies that included patients with advanced disease. Data from 19 publications, including randomised, prospective, and retrospective studies suggest that: long-term full-dose low-molecular-weight heparin (LMWH) is more effective than warfarin in the secondary prophylaxis of venous thromboembolism in patients with cancer of any stage, performance status, or prognosis; warfarin should not be used in patients with advancing progressive disease; and in patients at high risk of bleeding, full-dose LMWH for 7 days followed by a long-term decreased fixed dose long term can be considered. The optimum treatment duration is unclear, but because the prothrombotic tendency will persist in patients with advanced cancer, indefinite treatment is generally recommended. For patients with contraindications to anticoagulation, inferior-vena-caval filters can be considered, but their use needs careful patient selection. Ultimately, the decision to initiate, continue, and stop anticoagulation will need to be made on an individual basis, guided by the available evidence, the patient's circumstances, and their informed preferences. 相似文献
992.
We report an association of new technologies (the Onyx liquid embolic system and the Sonic microcatheter) for transarterial
embolization through the anterior branch of the middle meningeal artery of a dural arteriovenous fistula (DAVF) of the anterior
fossa. The place of endovascular treatment in anterior fossa DAVFs is reviewed, and its clinical implications discussed in
light of the case of a patient whose management was modified by this association of new technologies. 相似文献
993.
Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. 总被引:1,自引:1,他引:0
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
D Montagna R Maccario F Locatelli V Rosti Y Yang P Farness A Moretta P Comoli E Montini A Vitiello 《Blood》2001,98(12):3359-3366
Adoptive cellular immunotherapy has proven to be a successful approach in preventing and curing cytomegalovirus infection and Epstein-Barr virus-associated lymphomas after bone marrow transplantation. Translation of this approach for preventing leukemia relapse after bone marrow transplantation might require ex vivo priming and long-term maintenance of leukemia blast-specific T cells. To accomplish this goal, procedures were optimized for the in vitro priming of naive CD8 using dendritic cells activated by CD40 ligation, interleukin-12 (IL-12), and IL-7. Using T lymphocytes and dendritic cells obtained from HLA-matched allogeneic bone marrow transplantation donors and leukemia blasts as a source of tumor antigens, anti-acute myeloid leukemia cytotoxic T lymphocytes (CTLs) were induced. In these experiments, it was found that though it is possible to induce CTLs using immature dendritic cells, IL-12, and IL-7, obtaining long-term CTLs requires the presence of CD4 T cells in the priming phase. Using this approach, long-term antileukemia CTL lines could be generated from 4 of 4 bone marrow donors. Because this procedure does not require definition of the target antigen and because it selects responding cells from a virgin T-cell repertoire, its general application is suggested in adoptive immunotherapy and in the definition of tumor rejection antigens. 相似文献
994.
Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. 总被引:12,自引:8,他引:4
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The absolute content of CD34(+) cells in the peripheral blood of 84 patients with myelofibrosis with myeloid metaplasia (MMM) and 23 patients with other Philadelphia-negative (Ph(-)) chronic myeloproliferative disorders (CMDs) was investigated. In MMM, the median absolute number of circulating CD34(+) cells was consistently high (91.6 x 10(6)/L; range, 0-2460 x 10(6)/L). Receiver operating characteristic curve analysis showed that 15 x 10(6)/L as a decision criterion for CD34(+) cells produced an almost complete discrimination between MMM patients out of therapy and other Ph(-) CMDs (positive predictive value, 98.4%; negative predictive value, 85.0%). MMM patients with higher numbers of CD34(+) cells had a significantly longer disease duration (P =.019) and higher spleen volume index (P =.014), liver volume (P =.000), percentage of circulating immature myeloid cells (P =.020), and percentage of myeloid blasts (P =.000). When CD34(+) cells were correlated with the use of Dupriez risk stratification, CD34(+) cells increased significantly from low-risk (median, 68.1 x 10(6)/L) to intermediate-risk (median, 112.8 x 10(6)/L) and high-risk patients (median 666.1 x 10(6)/L) (F = 4.95; P =.009). When CD34(+) cells were correlated with a severity score on the basis of both myeloproliferative and myelodepletive characteristics of the disease, only the myeloproliferation index was significantly associated with CD34(+) cell level (F = 5.7; P =.000). Overall survival and interval to blast transformation from the time of CD34(+) cell analysis were significantly shorter in patients with more than 300 x 10(6)/L CD34(+) cells (P =.005 and.0005, respectively). In conclusion, the absolute number of CD34(+) circulating cells allows MMM to be distinguished from other Ph(-) CMDs; it is strongly associated with the extent of myeloproliferation and predicts evolution toward blast transformation. 相似文献
995.
INAUGURAL ARTICLE by a Recently Elected Academy Member:Modulation of intestinal gene expression by dietary zinc status: Effectiveness of cDNA arrays for expression profiling of a single nutrient deficiency 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
996.
997.
Ryan MM Kilham H Jacobe S Tobin B Isaacs D 《Journal of paediatrics and child health》2007,43(4):237-242
We present a baby with spinal muscular atrophy type 1, an inherited disorder causing progressive weakness, leading to complete paralysis of respiratory, facial and limb muscles. Without intervention, death occurs in infancy due to respiratory failure. Mechanical ventilatory support can prolong life, but the child's quality of life is highly debatable. We discuss the appropriateness of initiating and continuing intensive care for this child and others in a similar position. 相似文献
998.
Várkonyi J Szakály D Jánoskúti L Hosszúfalusi N Pánczél P Karádi I Schoket B 《Pathology oncology research : POR》2008,14(4):429-433
GSTM1, GSTT1 and GSTP1 Ile105Val that are members of the GST gene family encode for Phase II drug/xenobiotic metabolizing enzymes, primarily with detoxifying function, and are polymorphic
in humans. GSTM1 and GSTT1 homozygous deletion genotypes do not express the enzymes. It has been hypothesised that individuals with homozygous deletion
of the GSTM1 and/or GSTT1 gene may have lower detoxification capacity towards genotoxic agents therefore those individuals may be at increased risk
of myelodysplastic syndrome which is a preleukemic condition. Genetic polymorphism of GSTM1, GSTT1 and GSTP1 Ile105Val was investigated in a case–control study in a Hungarian patient population comprising 86 patients with myelodysplastic syndrome
and 99 hospital-based controls. There were no statistically significant differences between cases and controls for the GSTM1, GSTT1 and GSTP1 Ile105Val genotype frequencies for any of the three genes separately and in various combinations. This suggests that these genetic
polymorphisms may not be strong risk factors, if any, for myelodysplastic syndrome. 相似文献
999.
Kissinger P Schmidt N Mohammed H Leichliter JS Gift TL Meadors B Sanders C Farley TA 《Sexually transmitted diseases》2006,33(7):445-450
OBJECTIVES: Infections with Trichomonas vaginalis (TV) are common and recurrence rates are high. Better methods of treating partners of women with trichomoniasis are needed. GOAL: To determine if patient-delivered partner treatment (PDPT) is better and more cost-effective than partner referral. STUDY DESIGN: Women attending a family planning clinic who were culture-positive and treated for TV (N = 463) were randomized to either standard partner referral (PR), booklet-enhanced partner referral (BEPR), or PDPT. At baseline and 1 month, women were interviewed and cultured for TV. Detailed cost information was also collected. RESULTS: Most women had 1 partner, were less than 24 years old, and were black. The percentage of women reporting that their partners were treated was similar for PDPT but significantly lower for BEPR compared to PR. TV follow-up rates were similar. PDPT cost less and was cost saving compared to PR and BEPR. CONCLUSION: Among women with TV, PDPT did not result in more partners taking the medicine or lower follow-up rates than PR but was less costly. 相似文献
1000.